EUVIMEDEUVIMED entdecken
Open Access

SIK2 inhibitor SIC-19 enhances the sensitivity of PARP inhibitors in triple-negative breast cancers and pancreatic cancers

Qian Li, Shunpeng Zhu, Mingxian Zhu, Fang Wang, Jinhua Zhou

Oncology Research · 2025

DOI: 10.32604/or.2025.062539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Qian Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Poly(ADP-ribose) Polymerase Inhibitors, Pancreatic Neoplasms, Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsPoly(ADP-ribose) Polymerase InhibitorsPancreatic NeoplasmsProtein Serine-Threonine KinasesAntineoplastic Combined Chemotherapy ProtocolsHumansAnimalsFemaleMiceXenograft Model Antitumor AssaysCell Line, TumorApoptosisDrug SynergismCell ProliferationDrug Resistance, NeoplasmMice, Nude

Stichwörter der Autor:innen

PARP inhibitorPancreatic cancer (PC)SIC-19Salt-inducible kinase 2 (SIK2)Triple negative breast cancer (TNBC)

Substanzen

Poly(ADP-ribose) Polymerase InhibitorsProtein Serine-Threonine Kinasessalt-inducible kinase-2, human

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
  • Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, 215009, China.

Zitieren

APA

Li, Q., Zhu, S., Zhu, M., Wang, F., & Zhou, J. (2025). SIK2 inhibitor SIC-19 enhances the sensitivity of PARP inhibitors in triple-negative breast cancers and pancreatic cancers. Oncology Research. https://doi.org/10.32604/or.2025.062539

Vancouver

Li Q, Zhu S, Zhu M, Wang F, Zhou J. SIK2 inhibitor SIC-19 enhances the sensitivity of PARP inhibitors in triple-negative breast cancers and pancreatic cancers. Oncology Research. 2025. doi:10.32604/or.2025.062539

BibTeX
@article{Li2025,
  author = {Li, Qian and Zhu, Shunpeng and Zhu, Mingxian and Wang, Fang and Zhou, Jinhua},
  title = {SIK2 inhibitor SIC-19 enhances the sensitivity of PARP inhibitors in triple-negative breast cancers and pancreatic cancers},
  journal = {Oncology Research},
  year = {2025},
  doi = {10.32604/or.2025.062539}
}
Kostenlos starten →